Zynex: Abusive Pricing Model Unsustainable [Seeking Alpha]
Zynex, Inc. (ZYXI)
NASDAQ:AMEX Investor Relations:
zynexmed.com/ir-overview
Company Research
Source: Seeking Alpha
Zynex: Abusive Pricing Model Unsustainable Summary Zynex shares are up ~100x since late 2016 as retail investors buy into a story of rapid revenue and earnings growth. However, we believe Zynex is dependent on an abusive pricing strategy - reselling regular consumer batteries and electrodes at ~90% margins. Even slightly lower margins on these commodities would eliminate net income, suggesting how vulnerable the stock is here. We find it difficult to back into Zynex’s stated revenue per device. We've reported our concerns to Centers for Medicare and Medicaid Services, private insurers, and publications. On the surface, Zynex’s (NASDAQ: ZYXI Specifically, we calculate that, on each device, Zynex is collecting an average of $1,200 for non-proprietary batteries and electrodes, over the average 6 to 9-month life of a device. Using the standard Medicare fee schedule and allowing for higher rates from commercial insurers, we can't approximate this figure. We notified Zynex of our concern th
Show less
Read more
Impact Snapshot
Event Time:
ZYXI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ZYXI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ZYXI alerts
High impacting Zynex, Inc. news events
Weekly update
A roundup of the hottest topics
ZYXI
News
- Zynex Announces Partnership To Conduct Business with Veterans Affairs (VA) Medical Centers, the Largest Healthcare Network in the United StatesPR Newswire
- Zynex UCSF Study Results Demonstrate Laser Technology Benefits in Resolving Racial Bias of Current LED Pulse Oximeters [Yahoo! Finance]Yahoo! Finance
- Zynex UCSF Study Results Demonstrate Laser Technology Benefits in Resolving Racial Bias of Current LED Pulse OximetersPR Newswire
- ZYXI Stock Gains on the Completion of NiCO's Clinical Verification Trial [Yahoo! Finance]Yahoo! Finance
- Zynex, Inc. (NASDAQ: ZYXI) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $17.00 price target on the stock.MarketBeat
ZYXI
Sec Filings
- 12/6/24 - Form 4
- 12/3/24 - Form 4
- 11/18/24 - Form 4
- ZYXI's page on the SEC website